Search research articles
Contact Us
Filters
Showing results (551-560 of 632) with videos related to
Page
of 64
Sort By:
Free Radical Biology & Medicine
|
November 3, 2009
Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia
Magnus G Olsson, Magnus Centlow, Sigurbjörg Rutardóttir, et al.
American Heart Journal
|
December 18, 2002
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
Anders G Olsson, Helge Istad, Olavi Luurila, et al.
Circulation
|
January 7, 1998
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)
T A Miettinen, K Pyörälä, A G Olsson, et al.
Circulation
|
September 17, 2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
Scott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
BMJ (Clinical Research Ed.)
|
March 1, 1997
Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50
M Kristenson, B Ziedén, Z Kucinskienë, et al.
Circulation
|
February 1, 1988
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism
M Verstraete, G A Miller, H Bounameaux, et al.
European Heart Journal
|
March 15, 2005
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial
Anders G Olsson, Gregory G Schwartz, Michael Szarek, et al.
International Journal of Cardiology
|
September 5, 2013
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
Matti J Tikkanen, Rana Fayyad, Ole Faergeman, et al.
American Journal of Obstetrics and Gynecology
|
March 29, 2011
Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia
Ulrik Dolberg Anderson, Magnus G Olsson, Sigurbjörg Rutardóttir, et al.
Molecular and Cellular Endocrinology
|
August 15, 2000
Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway
L Kanter-Lewensohn, L Girnita, A Girnita, et al.
Page
of 64
Search research articles
Search
Showing results (551-560 of 632) with videos related to
Sort By:
Page
of 64
Free Radical Biology & Medicine
|
November 3, 2009
Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia
Magnus G Olsson, Magnus Centlow, Sigurbjörg Rutardóttir, et al.
American Heart Journal
|
December 18, 2002
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
Anders G Olsson, Helge Istad, Olavi Luurila, et al.
Circulation
|
January 7, 1998
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)
T A Miettinen, K Pyörälä, A G Olsson, et al.
Circulation
|
September 17, 2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
Scott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
BMJ (Clinical Research Ed.)
|
March 1, 1997
Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50
M Kristenson, B Ziedén, Z Kucinskienë, et al.
Circulation
|
February 1, 1988
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism
M Verstraete, G A Miller, H Bounameaux, et al.
European Heart Journal
|
March 15, 2005
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial
Anders G Olsson, Gregory G Schwartz, Michael Szarek, et al.
International Journal of Cardiology
|
September 5, 2013
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
Matti J Tikkanen, Rana Fayyad, Ole Faergeman, et al.
American Journal of Obstetrics and Gynecology
|
March 29, 2011
Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia
Ulrik Dolberg Anderson, Magnus G Olsson, Sigurbjörg Rutardóttir, et al.
Molecular and Cellular Endocrinology
|
August 15, 2000
Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway
L Kanter-Lewensohn, L Girnita, A Girnita, et al.
Page
of 64